Design and characterization of a human milk product for the preterm infant.
BACKGROUND
It is necessary to fortify human milk to promote optimal growth of the very preterm infant. However, the addition of non-human milk components to human milk is not ideal because of the risk of feeding intolerance and necrotizing enterocolitis. Human milk products (HMP) are an alternative to commercially available fortifiers, but their preparation is likely to result in modifications to the qualities of human milk.


METHODS
Ten batches of HMP were prepared with the aim of meeting a desired protein:energy ratio of 3.0 g of protein/100 kcal. Ultrafiltration was used to produce a skim milk concentrate, to which cream was then added to produce the final HMP. Characterization of HMP and human milk fortified with commercial human milk fortifiers (Nutriprem [Cow & Gate, Limerick, Ireland] and S-26 SMA human milk fortifier [Wyeth Nutrition, Baulkham Hills, NSW, Australia]) included quantifying macronutrient content, osmolality, microbial content, and particle distribution.


RESULTS
Average protein:energy ratio of the final batch was 2.93 +/- 0.10 g of protein/100 kcal, equating to an inaccuracy of 2.5% relative to the desired ratio of 3.0 g of protein/100 kcal. Significantly greater fat (P < 0.01), lower lactose (P < 0.001), and lower osmolality (P < 0.001) were characteristic of the HMP compared to human milk fortified with either commercial fortifier. Microbial growth occurred during preparation of HMP but did not exceed 10(5) colony-forming units/mL, and pasteurization of human milk prevented contamination in 80% of batches.


CONCLUSIONS
HMP can be designed to accurately target the protein and energy requirements of the preterm infant, but modifications of the macronutrient, biochemical, structural, and microbial characteristics of human milk may affect the quality of the final product.
Czank
Charles
C
Discipline of Biochemistry and Molecular Biology, School of Biomedical, Biomolecular, and Chemical Science, The University of Western Australia, Crawley, Western Australia, Australia. chuck@tartarus.uwa.edu.au
Simmer
Karen
K
Hartmann
Peter E
PE
D004041:Dietary Fats / Q000008:administration & dosage* / Q000032:analysis; D002149:Energy Intake; D005506:Food Contamination / Q000032:analysis; D005527:Food, Fortified; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature / Q000254:growth & development*; D007785:Lactose / Q000008:administration & dosage / Q000032:analysis; D008894:Milk Proteins / Q000008:administration & dosage* / Q000032:analysis; D008895:Milk, Human / Q000737:chemistry* / Q000382:microbiology; D009751:Nutritional Requirements; D009994:Osmolar Concentration; D015430:Weight Gain
D004041:Dietary Fats; D008894:Milk Proteins; D007785:Lactose